Angiotensin II receptor blockers (Q81461133)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Angiotensin II receptor blockers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Amy Barreras

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cheryle Gurk-Turner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

Baylor University Medical Center Proceedings

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

123-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators

9 January 2020

cites work

1 reference

12 December 2020

Angiotensin II receptor antagonists

1 reference

12 December 2020

Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension

1 reference

12 December 2020

A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesar

1 reference

12 December 2020

Angiotensin II-receptor blockers: clinical relevance and therapeutic role

1 reference

12 December 2020

ELITE II and Val-HeFT are different trials: together what do they tell us?

1 reference

12 December 2020

Angiotensin II type 1 receptor blockers

1 reference

12 December 2020

A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II.

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension

1 reference

12 December 2020

ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension

1 reference

12 December 2020

10.1080/08998280.2003.11927893

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16278727%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

16278727

1 reference